Title
Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009
Date Issued
01 April 2014
Access level
open access
Resource Type
journal article
Author(s)
Lipsitz M.C.
Castro J.L.
Medrano C.
Clark J.L.
Lake J.E.
Cabello R.
University of California at Los Angeles David Geffen School of Medicine
U.S. Naval Medical Research Unit No. 6
Publisher(s)
Royal Society of Medicine Press Ltd
Abstract
Mobile unit (MU) HIV testing is an alternative method of providing healthcare access. We compared demographic and behavioural characteristics, HIV testing history and HIV prevalence between participants seeking testing at a MU vs. fixed clinic (FC) in Lima, Peru. Our analysis included men and transgender women (TW) in Lima aged ≥ 18 years old seeking HIV testing at their first visit to a community-based MU or FC from October 2007 to November 2009. HIV testing history, HIV serostatus and behavioural characteristics were analysed. A large percentage of MU attendees self-identified as transgender (13%) or heterosexual (41%). MU attendees were more likely to engage in transactional sex (24% MU vs. 10% FC, p < 0.001), use alcohol/drugs during their last sexual encounter (24% MU vs. 20% FC, p < 0.01) and/or be a first-time HIV tester (48% MU vs. 41% FC, p < 0.001). MU HIV prevalence was 9% overall and 5% among first-time testers (49% in TW and 11% in men who have sex with men [MSM] first-time testers). MU testing reached large numbers of at-risk (MSM/TW) populations engaged in unsafe sexual behaviours, making MU outreach a worthy complement to FC testing. Investigation into whether MU attendees would otherwise access HIV testing is warranted to determine the impact of MU testing. © The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Start page
325
End page
331
Volume
25
Issue
5
Language
English
OCDE Knowledge area
UrologĂ­a, NefrologĂ­a
Scopus EID
2-s2.0-84898684820
PubMed ID
Source
International Journal of STD and AIDS
ISSN of the container
0956-4624
Sponsor(s)
This work was supported by the South American Program in HIV Prevention Research (SAPHIR) through the David Geffen School of Medicine Program in Global Health [NIH R25 MH087222 (South American Program in HIV Prevention Research)]. Funding for the SOMOS project was provided by HIVOS and the European Commission.
Sources of information: Directorio de ProducciĂłn CientĂ­fica Scopus